SCHEMBL6357965

SCHEMBL6357965

CCn1ccnc1-c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.47
NPC1 O15118 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TSHR P16473 1/20 0.47
KDM4E B2RXH2 6/20 0.46
LMNA P02545 3/20 0.46
CCR1 P32246 2/20 0.46
CCR5 P51681 2/20 0.46
CCR8 P51685 2/20 0.46
CYP1A2 P05177 2/20 0.46
POLB P06746 1/20 0.46
METAP1 P53582 1/20 0.46
BLM P54132 1/20 0.46
HIF1A Q16665 1/20 0.46
DOHH Q9BU89 1/20 0.46
P4HTM Q9NXG6 1/20 0.46
FLT3 P36888 2/20 0.41
GSK3B P49841 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALOX15 P16050 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28060015 0.86 NPC1 (0.44) TP53NPC1SMN1; SMN2TSHRKDM4E
SCHEMBL27908771 0.83 POLB (0.57) TP53NPC1SMN1; SMN2TSHRKDM4E
SCHEMBL5612943 0.82 TLR8 (0.53) TP53NPC1SMN1; SMN2TSHRKDM4E
Hydrochloric Acid SCHEMBL7173136 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7177034 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7177916 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7180472 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7175727 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7176630 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA
Hydrochloric Acid SCHEMBL7171336 0.81 KMT2A (0.43) TP53SMN1; SMN2TSHRKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357286-A1 KETONE SYNTHESIS AND APPLICATIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-11-09 US disclosed
US-7413818-B2 Light-emitting device CANON KABUSHIKI KAISHA (JP) 2008-08-19 US disclosed
US-7413818-B2 Light-emitting device CANON KABUSHIKI KAISHA (JP) 2008-08-19 US disclosed
US-6929873-B2 Electroluminescent device using metal coordination compound CANON KABUSHIKI KAISHA (JP) 2005-08-16 US disclosed
US-20040013905-A1 Electroluminescent device using metal coordination compound CANON KABUSHIKI KAISHA (JP) 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357286-A1 KETONE SYNTHESIS AND APPLICATIONS NISCH, COASY, KLK7 TP53 4243/4885NPC1 1038/4885SMN1; SMN2 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.